Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Large-scale testing (Phase 3)Ended earlyNCT03013946
What this trial is testing

Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy

Who this might be right for
Renal Cell Carcinoma, MetastaticRenal Cell Cancer, Recurrent
AIO-Studien-gGmbH 121
Testing effectiveness (Phase 2)Study completedNCT00425386
What this trial is testing

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 60
Testing effectiveness (Phase 2)Ended earlyNCT02423954
What this trial is testing

Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

Who this might be right for
Advanced CancerPancreatic CancerRenal Cell Cancer+4 more
Western Regional Medical Center 33
Testing effectiveness (Phase 2)Ended earlyNCT03876925
What this trial is testing

A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC

Who this might be right for
Renal Cell Cancer Metastatic
Sunshine Lake Pharma Co., Ltd. 10
Early research (Phase 1)Study completedNCT00478725
What this trial is testing

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Testing effectiveness (Phase 2)Study completedNCT01664182
What this trial is testing

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 41
Not applicableStudy completedNCT00873210
What this trial is testing

Study In Patients With Kidney Cancer Treated With Sutent

Who this might be right for
Advanced or Metastatic Renal Cell CarcinomaRenal Cancer
Pfizer 121
Early research (Phase 1)Looking for participantsNCT07623369
What this trial is testing

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Huahui Health 299
Testing effectiveness (Phase 2)Looking for participantsNCT07469683
What this trial is testing

An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaNeoplasmsMalignant Neoplasms+1 more
Yonsei University 78
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00960063
What this trial is testing

Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Who this might be right for
NeoplasmsSolid TumorsBone Cancer+2 more
Merck Sharp & Dohme LLC 4
Testing effectiveness (Phase 2)Study completedNCT00827359
What this trial is testing

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaRenal Cancer
Beth Israel Deaconess Medical Center 25
Early research (Phase 1)UnknownNCT06049030
What this trial is testing

HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd. 190
Early research (Phase 1)Ended earlyNCT05229601
What this trial is testing

HFB301001 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Soft Tissue SarcomaRenal Cell CarcinomaUterine Carcinosarcoma+3 more
HiFiBiO Therapeutics 31
Testing effectiveness (Phase 2)Study completedNCT00277017
What this trial is testing

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Who this might be right for
KidneyCancer
New Mexico Cancer Research Alliance 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05863351
What this trial is testing

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
ECOG-ACRIN Cancer Research Group 472
Early research (Phase 1)Ended earlyNCT03260504
What this trial is testing

Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+1 more
University of Washington 6
Next Page